VISTN Vistin Pharma ASA
18.10NOK-0.82%Mkt Cap: 75.65M $P/E: 11.55Today
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; m…
Industry Peers
Drug Manufacturers - Specialty & Generic$66.23BUSDP/E 25.7
$58.68BUSD
$45.70BUSDP/E 65.3
GALD
Galderma Group AG$43.27BUSDP/E 56.1
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG$34.93BUSDP/E 60.5
HLN
Haleon plc$32.73BUSDP/E 19.0
$29.57BUSDP/E 11.8
$28.56BUSDP/E 12.2
$23.38BUSDP/E 19.5
$20.09BUSD
$14.43BUSDP/E 112.9
$14.58BUSDP/E 21.0
$12.99BUSDP/E 23.5
$11.17BUSD
$10.22BUSDP/E 27.9
$8.66BUSDP/E 19.3
$6.95BUSDP/E 109.1
$6.89BUSD
$6.84BUSDP/E 40.1
| Headline | Source | Time |
|---|---|---|
Older | ||
Vistin Pharma ASA (STU:VP4) (Q2 2026) Earnings Call Highlights: Strategic Resilience Amid ... Vistin Pharma ASA (STU:VP4) navigates a 9% revenue dip with strong 66% gross margins, while advancing its new DC 95% product and securing long-term energy stability. | ||
DDagens Medisin | ||